Avenue Therapeutics
(OTC) ATXI
Avenue Therapeutics Financials at a Glance
Market Cap
$732,200
Revenue (TTM)
$1.40M
Net Income (TTM)
$3.74M
EPS (TTM)
$-1.46
P/E Ratio
-0.16
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$0.29
Volume
8,240
Open
$0.29
Price
$0.29
Volume
8,240
Open
$0.29
Previous Close
$0.29
Daily Range
$0.29 - $0.29
52-Week Range
$0.15 - $0.97
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$0.29
Volume
8,240
Open
$0.29
Previous Close
$0.29
Daily Range
$0.29 - $0.29
52-Week Range
$0.15 - $0.97
ATXI News
ATXI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avenue Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Alexandra MacLean, MD, MBA
Website
www.avenuetx.comHeadquarters
New York City, NY 10036, US
ATXI Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-121%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-6.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$732.20K
Shares Outstanding
3.18M
Volume
8.24K
Short Interest
0.00%
Avg. Volume
5.80K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$11.28M
EBITDA
$11.70M
Operating Cash Flow
$9.03M
Capital Expenditure
$0.00
Free Cash Flow
$9.03M
Cash & ST Invst.
$2.59M
Total Debt
$0.00
Avenue Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$732.20K
N/A
Market Cap/Employee
$366.10K
N/A
Employees
2
N/A
Net Income
$683.00K
+77.8%
EBITDA
$683.00K
+77.4%
Quarterly Fundamentals
Net Cash
$3.71M
+42.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.01%
N/A
Return on Invested Capital
-1.71%
N/A
Free Cash Flow
$383.00K
+113.3%
Operating Cash Flow
$383.00K
+113.3%